Skip to content
Home/Companies/Digital Health/Predilepsy
Predilepsy

Predilepsy

Digital Health·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Predilepsy?

Predilepsy is currently owned by Elaia Partners through Elaia Endowment Fund (2020 vintage), since 2021.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
Elaia Endowment Fund · 2020 · VC

Key facts

HQFrance
SectorDigital Health
Websitewww.predilepsy.org

More from Elaia Endowment Fund

Other portfolio companies in the same fund.

QBio JRC
Active
BiotechFrance· 2022
Sensation Quantique
Sensation Quantique
Active
HealthTechFrance· 2022
Pyronear
Pyronear
Active
AI/MLFrance· 2021
Institut Analgesia
Institut Analgesia
Active
HealthTechFrance· 2020

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Predilepsy

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Predilepsy?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Predilepsy.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue